Literature DB >> 21241798

Apoptosis in polycystic kidney disease.

Béatrice Goilav1.   

Abstract

Apoptosis is the process of programmed cell death. It is a ubiquitous, controlled process consuming cellular energy and designed to avoid cytokine release despite activation of local immune cells, which clear the cell fragments. The process occurs during organ development and in maintenance of homeostasis. Abnormalities in any step of the apoptotic process are associated with autoimmune diseases and malignancies. Polycystic kidney disease (PKD) is the most common inherited kidney disease leading to end-stage renal disease (ESRD). Cyst formation requires multiple mechanisms and apoptosis is considered one of them. Abnormalities in apoptotic processes have been described in various murine and rodent models of PKD as well as in human PKD kidneys. The purpose of this review is to outline the role of apoptosis in progression of PKD as well as to describe the mechanisms involved. This article is part of a Special Issue entitled: Polycystic Kidney Disease.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21241798     DOI: 10.1016/j.bbadis.2011.01.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  30 in total

1.  Smac-mimetic-induced epithelial cell death reduces the growth of renal cysts.

Authors:  Lucy X Fan; Xia Zhou; William E Sweeney; Darren P Wallace; Ellis D Avner; Jared J Grantham; Xiaogang Li
Journal:  J Am Soc Nephrol       Date:  2013-08-29       Impact factor: 10.121

Review 2.  The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease.

Authors:  Tamina Seeger-Nukpezah; Daniel M Geynisman; Anna S Nikonova; Thomas Benzing; Erica A Golemis
Journal:  Nat Rev Nephrol       Date:  2015-04-14       Impact factor: 28.314

3.  Disruption of IFT complex A causes cystic kidneys without mitotic spindle misorientation.

Authors:  Julie A Jonassen; Jovenal SanAgustin; Stephen P Baker; Gregory J Pazour
Journal:  J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 10.121

Review 4.  T Cells and Regulated Cell Death: Kill or Be Killed.

Authors:  Johan Spetz; Adam G Presser; Kristopher A Sarosiek
Journal:  Int Rev Cell Mol Biol       Date:  2018-08-29       Impact factor: 6.813

Review 5.  Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease.

Authors:  Peter C Harris; Vicente E Torres
Journal:  J Clin Invest       Date:  2014-06-02       Impact factor: 14.808

6.  The consequences of increased 4E-BP1 in polycystic kidney disease.

Authors:  Sara J Holditch; Carolyn N Brown; Daniel J Atwood; Deepak Pokhrel; Sara E Brown; Andrew M Lombardi; Khoa N Nguyen; Ryan C Hill; Miguel Lanaspa; Katharina Hopp; Mary C M Weiser-Evans; Charles L Edelstein
Journal:  Hum Mol Genet       Date:  2019-12-15       Impact factor: 6.150

Review 7.  Why kidneys fail in autosomal dominant polycystic kidney disease.

Authors:  Jared J Grantham; Sumanth Mulamalla; Katherine I Swenson-Fields
Journal:  Nat Rev Nephrol       Date:  2011-08-23       Impact factor: 28.314

Review 8.  Heterotrimeric G protein signaling in polycystic kidney disease.

Authors:  Taketsugu Hama; Frank Park
Journal:  Physiol Genomics       Date:  2016-05-13       Impact factor: 3.107

9.  Constitutive renal Rel/nuclear factor-κB expression in Lewis polycystic kidney disease rats.

Authors:  Michelle H T Ta; Kristina G Schwensen; David Liuwantara; David L Huso; Terry Watnick; Gopala K Rangan
Journal:  World J Nephrol       Date:  2016-07-06

Review 10.  Functional and therapeutic importance of purinergic signaling in polycystic kidney disease.

Authors:  Daria V Ilatovskaya; Oleg Palygin; Alexander Staruschenko
Journal:  Am J Physiol Renal Physiol       Date:  2016-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.